Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ

Summary

Purpose: to develop an international validated patient-reported outcome measure for COVID-19 patients according to international guidelines.

In this phase III of the project, the preliminary questionnaire of 80 items will be tested. It has been developed based on literature review and interviews with health care professionals and patients (phase I-II).

In Phase III A patients will fill in the questionnaire followed by interviews on relevance, importance and wording of the questionnaire In Phase III B patients will fill in the questionnaire and an debriefing questionnaire. We will do explorative psychometric analyses.

Conditions

• Covid19, Patient Reported Outcome Measures, Quality of Life

Interventions

OTHER

No intervention. Method study. Psychometric testing

Patients will fill in the questionnaire followed by an interview (phase IIIA) or a debriefing questionnaire (Phase IIIB)

Sponsors & Collaborators

• European Organisation for Research and Treatment of Cancer - EORTC

  collaborator NETWORK

• Medical University Innsbruck

  collaborator OTHER

• Johannes Gutenberg University Mainz

  collaborator OTHER

• Servicio de Navarro de Salud

  collaborator UNKNOWN

• University of Southampton

  collaborator OTHER

• Skane University Hospital

  collaborator OTHER

• Haukeland University Hospital

  collaborator OTHER

• University of the East Ramon Magsaysay Memorial Medical Center

  collaborator UNKNOWN

• Sumandeep Vidyapeeth

  collaborator OTHER

• Birzeit University

  collaborator UNKNOWN

• National Centre for Infectious Diseases

  collaborator UNKNOWN

• Komfo Anokye Teaching Hospital

  collaborator OTHER

• Oslo University Hospital

  lead OTHER

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-11-20

Primary Completion

2022-01-15

Completion

2022-09-15

Countries

• Norway

Study Locations